Skip to main content

Table 1 Study characteristics

From: The impact of Centre’s heart transplant status and volume on in-hospital outcomes following extracorporeal membrane oxygenation for refractory post-cardiotomy cardiogenic shock: a meta-analysis

StudyStudy time framesPrevalence (%)N. of ptsAge (years)Male(%)LVEF (%)Baseline sCr (mg/dL)Status elective/ urgent/ emergency/ salvage (n)Surgery (n)  
CABGValveCombinedOtherCPBX-clamp
HTx/VAD centres  
 Acheampong 20162001–20131.062441 (IQR: 22–75)58.347 (10–66)NRNR01437NRNR
 Bakhtiary 20082003–20060.784560.1 ± 13.677.825.8 ± 10NRNR2021112NRNR
 Beckmann 20171997–2011NR850.1 ± 15.862.5NRNRNR/NR/3/NR0413NRNR
 Beiras-Fernandez 20111996–2006NR7349.3 ± 18.064.4NR1.8 ± 1.1NR1413640254.3110.9
 Biancari 20172005–20160.6014865.4 ± 9.478.4NRNR19/34/80/1514800014668
 Burrell 20152007–2013NR5448 (IQR: 34–58)68.5NR1.2 (0.9–1.6)NRNRNRNR
 Carroll 20152009–2014NR2656 (IQR: 41–65)*69.1*30 (17–57)*NRNRNRNRNR
 Chen 2011*2002–2008NR6047 ± 260.8NR1.3 ± 0.1NRNRNRNR
 Combes 20082003–2006NR1646 ± 16*56.8*NRNRNRNRNRNR
 Distelmeier 20162003–20143.3535465 (IQR: 55–73)68.6NR1.3 (1.1–1.8)NR4811084111NRNR
 Doll 20031997–20001.209559.8 ± 13.369.546 ± 17.4NR21/64/10/0631886NRNR
 Elsharkawy 20101995–20050.58233NR67.4NRNRNR/NR/84/NRNRNRNR
 Fiser 20011993–20000.915161.0 ± 1.756.9NRNRNR34557172.368.6
 Guihaire 20172005–20140.709264.5 (18–83)5947.2 ± 17.41.16 ± 0.58NR/NR/33/NR126431**16173.3109.5
 Hsu 20092002–20062.895163.0 ± 15.770.640.1 ± 17.9NRNR27117618832
 Kanji 2010*2002–2006NR5049.367223.0NRNRNRNRNR
 Ko 20021994–20002.617656.8 ± 15.963.2NRNRNR3714619NRNR
 Lamarche 20102000–20080.302454.6 ± 216320 ± 25NRNRNRNRNR
 Li 20152011–20120.9112356.2 ± 11.865.954.6 ± 13.6NRNR44401524NRNR
 Liden 20092000–2007NR3352.4 ± 12.793.9NRNRNR100023NRNR
 Liu 20092002–20050.581455.7 ± 15.45052.9 ± 21.41.3 ± 1.1NR1724247132
 Loforte 20142006–20121.2715558.2 (23–84)*65.8*48.2 (33–75)*NRNR28433252214.5NR
 Luo 20092005–2008NR3649.772.2NRNRNR158013NRNR
 Mazzeffi 20162010–20150.422357 ± 1560.950 (40–55)1.2 (0.9–2.0)NR76010160NR
 Meyer 20092007–20071.231850 ± 1572.2NRNRNR52010237NR
 Musial 20172009–2016NR2745 ± 1670.433.1 ± 22.3NRNR016011NRNR
 Papadopoulos 20152001–2013NR36062 ± 1776.135NRNR/NR/NR/5011489857216071
 Park 20142005–2012NR11561.7 ± 13.448.757.1 ± 14.3NRNR25313326232.4104.7
 Peigh 20152010–2014NR1348 ± 14*64.4*NR1.5 ± 0.8*NRNRNRNR
 Pokersnik 20122005–2010NR4965 ± 1367.3NRNRNR/NR/0/0NR239110
 Pontailler 20172004–2014NR12775.7 ± 4.7*61.3*23 ± 121.9 ± 1.0NR/NR/49/NR42361818NRNR
 Ranucci 20112008–2011NR11NRNRNRNRNR  NR 283.1NR
 Rastan 20101996–20081.2851763.5 ± 11.271.519.9NR159/122/205/31193967215617984.6
 Rousse 2015NRNR2950.6 ± 15.465.5NRNRNRNRNRNR
 Rubino 20172008–2016NR10157.1 ± 15.863.4NRNRNR0122960278.2NR
 Russo 20102005–2009NR363.3 ± 14.566.7NR1,3 ± 0.1NR1101NRNR
 Saxena 20152003–2013NR4576.8 ± 4.668.948.51.4 ± 0.535/6/4/0NRNRNR
 Slottosch 20122006–2010NR7760 ± 1376.642 ± 19NRNR/NR/29/NR4310111317369
 Slottosch 20172008–2016NR10058 ± 15*76.3NRNRNR/NR/37/04519241217068
 Truby 2015 *2007–2013NR7056.9 ± 16.167.6NR1.83 ± 1.09NR1121NR8NRNR
 Tsai 20162002–2011NR6757 ± 14*66.7*NR1.71 ± 2.17*NR  NR NRNR
 Wang 20092004–20080.496251 ± 1551.650 ± 16NRNR133946NRNR
 Wang 20132004–20111.798765 ± 758.646 ± 12NRNR  NR 18294
 Wu 20102003–20092.6311060 ± 1470.943.4 ± 19.2NRNR/NR/31/NR31421918224126
 Xie 2017***2011–2015NR273NRNRNRNRNR  NR NRNR
 Zhang 20061996–2004NR3255.4 ± 11.956.355.3 ± 14.8NRNR51012523798.7
 Zhao 20152004–2012NR2459.3 ± 11.979.251.8 ± 14.2NRNR20202NRNR
 Zhong 20172009–20160.643650.4 ± 12.291.760.6 ± 7.86NRNR/NR/9/NR  NR 279113
Non-HTx/VAD centres  
 Ariyaratnam 20142003–2013NR1465.6 ± 10.557.1NRNRNR00113205.6109.6
 Deschka 20132008–2011NR2866.6 ± 5.392.937.2 ± 13.0NRNR171100NRNR
 Khorsandi 20161995–2015NR1564.3 ± 14.573.3NRNR9/3/4/03453NRNR
 Mikus 20132007–20110.261453.1 ± 14.364.346.1 ± 13.9NR6/2/6/05630240.598.4
 Raffa 20172007–2017NR8665 ± 11.265.1NRNRNR/NR/33/NR19142924197104
 Unosawa 20121992–2007NR4764.4 ± 12.574.447.8 ± 19.1NRNR/NR/22/NR19861421781.2
  1. * Reported for entire study population including non-PCS patients
  2. ** Multiple valve repair or valvular surgery combined with CABG; potential overlap
  3. *** Article in Chinese – data from English abstract
  4. One patient had transfemoral transcatheter aortic valve replacement
  5. Values are reported as mean ± SD, unless reported otherwise in the original manuscript. Numbers of patients in single studies do not always match the total n. of patients in the original manuscripts since only PCS subgroups were considered. Slottosch 2012 and Slottosch 2017 are studies from the same group; first [Additional file 1 reference 39] describes ECMO support after surgery for acquired heart disease from 2006 to 2010, the second [Additional file 1: reference 40] reports all patients receiving ECMO support longer than 48 h for cardiogenic shock from 01/2008 to 12/2016 therefore, there exists a potential overlap of included patients. LVEF, left ventricle ejection fraction; sCr, serum creatinine; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; IQR, interquartile range; NR, not reported